Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

7 Stocks to Buy for the Rest of 2023

By Muslim Farooque, InvestorPlace Contributor
With the stock market off to a bombastic start, these top stocks for 2023 are worth betting on for the remainder of the year

3 Very Oversold Biotech Stocks to Buy Right Now

By Larry Ramer, InvestorPlace Contributor
These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong. 

Timeless Titans: 3 Blue-Chip Stocks Destined for 100% Gains by 2024

By Faisal Humayun, InvestorPlace Contributor
These are the blue-chip stocks to buy and hold at undervalued levels as they are poised for a big reversal in sentiment

Market Crash Coming? 3 Stocks to Buy for a Soft Landing

By Joel Baglole, InvestorPlace Contributor
Count on these companies to remain resilient even if higher interest rates push the economy into a market crash.

Why Is Novocure (NVCR) Stock Down 30% Today?

By Josh Enomoto, InvestorPlace Contributor
Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.

RAD Stock Alert: Will Rite Aid Be the Next Big Short Squeeze?

By Larry Ramer, InvestorPlace Contributor
RAD stock sank 50% on Friday amid reports that Rite Aid will soon declare bankruptcy. Will RAD stock be the next short squeeze?

Why Is Myomo (MYO) Stock Down 13% Today?

By William White, InvestorPlace Writer
Myomo (MYO) stock is dropping on Monday after the wearable medical robotics company priced a $4.4 million public share offering.

Why Is Rite Aid (RAD) Stock Down Today?

By William White, InvestorPlace Writer
Rite Aid (RAD) stock is falling on Monday following reports that the pharmaceutical company is preparing to file for bankruptcy.

These Are the ONLY 3 Cannabis Stocks to Consider in August 2023

By Larry Ramer, InvestorPlace Contributor
With Congress close to allowing cannabis companies to access the financial system, here are three great cannabis stocks.

The 3 Blue-Chip Stocks Every Investor Needs to Own Today

By Rick Orford, InvestorPlace Contributor
These three blue-chip stocks are all industry giants in their respective sectors — and offer future growth and stability.

3 Penny Stocks You’ll Regret Not Buying Soon

By Matthew Farley, InvestorPlace Contributor
There are plenty of penny stocks to buy, but not all of them are created equal. Here are some of the best options to choose from.

3 Growth Stocks to Ride the Coming Bull Market in Style

By Rich Duprey, InvestorPlace Contributor
Stocks are rallying once again in 2023. The growth-oriented index is leading the way higher with a 36% gain or more than twice the return…

The GMO Frontier: 3 Synthetic Biology Stocks for Your Must-Buy List

By John Blankenhorn, InvestorPlace Contributor
The industries of the future are already available for investing today. Don't get left behind as synthetic biology stocks build the future.

Protect Your Portfolio and Rotate Into Healthcare Stocks Now

By Michael A. Gayed
Healthcare stocks are starting to outperform as tech stocks start to falter. Making a rotation now can help you survive what's to come.

Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases

By John Blankenhorn, InvestorPlace Contributor
Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.

Why Is YS Biopharma (YS) Stock Up 71% Today?

By William White, InvestorPlace Writer
YS Biopharma (YS) stock is rising higher on Friday after the biopharmaceutical company announced officers purchasing shares.

7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole

By Louis Navellier and the InvestorPlace Research Staff
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.

T2 Biosystems Preps to Resell 141 Million Shares of TTOO Stock

By Eddie Pan, InvestorPlace Financial News Writer
TTOO stock is in the red after the company filed for the resale of up to 141.64 million shares for CR Group L.P.

GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment

By William White, InvestorPlace Writer
Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.
Load More Articles